Name: KLOW 80mg
Brand: RetaLABS
SKU: klow-80mg
Price: 150.00 AUD
Availability: InStock
Rating: 5.0 (4 reviews)

Question 1

What is KLOW used for in research?

Accepted Answer

KLOW is used in preclinical research investigating the combined effects of four well-characterised tissue-repair and regenerative compounds on multi-pathway healing mechanisms. Each component contributes a distinct mechanistic profile: GHK-Cu (Glycine-Histidine-Lysine copper complex) modulates the expression of thousands of genes involved in collagen synthesis, anti-inflammatory signalling, and wound healing, making it a broad transcriptional modulator in addition to its direct tissue-repair roles. KPV (Lys-Pro-Val), as a C-terminal fragment of α-MSH, attenuates inflammatory signalling through NF-κB pathway inhibition and melanocortin receptor modulation. BPC-157 promotes angiogenesis, fibroblast activity, and tissue vascularisation through VEGF and FAK-paxillin pathways. TB-500 modulates actin dynamics via G-actin sequestration, enhancing cell migration into repair sites. KLOW is designed for researchers studying these overlapping but mechanistically distinct pathways in a single experimental system, with consistent compound ratios across all preparations.

Question 2

What is GHK-Cu and why is it in this blend?

Accepted Answer

GHK-Cu (Glycine-Histidine-Lysine copper complex) is a naturally occurring tripeptide-copper chelate found at nanomolar concentrations in human plasma, urine, and saliva. Its plasma concentration declines significantly with age, which has made it a subject of longevity and regenerative research. GHK-Cu's biological activity in research models is broad and complex: it stimulates the production of collagen, proteoglycans, and glycosaminoglycans in fibroblasts, promotes angiogenesis, and modulates the expression of a remarkably large number of genes. One genomics analysis identified over 4,000 genes whose expression was modulated by GHK-Cu in human skin cells. Its mechanism of transcriptional modulation is thought to operate through copper-dependent activation of transcription factors and indirect effects on histone deacetylase activity. In the KLOW blend, GHK-Cu contributes the transcriptional regulation and collagen synthesis component, complementing the more targeted anti-inflammatory (KPV) and structural repair (BPC-157, TB-500) activities of the other three components.

Question 3

How should KLOW be reconstituted?

Accepted Answer

Reconstitute KLOW with bacteriostatic water using standard lyophilised peptide technique. Draw the required diluent volume into a syringe and inject slowly along the inner wall of the vial, allowing the solution to run down and contact the lyophilised powder gradually (do not inject directly onto the cake). Gently swirl the vial in circular motions until all powder is dissolved. KLOW contains four co-lyophilised peptides of varying molecular weights (GHK-Cu ~340 Da, KPV ~356 Da, BPC-157 ~1.4 kDa, TB-500 ~878 Da); all dissolve readily in bacteriostatic water. The resulting solution should be clear to slightly coloured; GHK-Cu, being a copper complex, can impart a faint blue tint at higher concentrations, which is normal. Store reconstituted solution at 2–8°C and use within four weeks. Keep lyophilised vials at −20°C prior to reconstitution. Avoid vigorous shaking or vortexing.

Question 4

Why choose a blend over individual components?

Accepted Answer

The KLOW blend enables researchers to investigate the combined effects of four mechanistically complementary compounds without managing four separate vials, reconstitution events, and volume calculations per preparation. The co-lyophilised formulation ensures that every reconstituted aliquot contains GHK-Cu, KPV, BPC-157, and TB-500 at a consistent 50:10:10:10 mg ratio (eliminating inter-preparation variability that could arise from sequential mixing of individually reconstituted solutions). For researchers new to multi-peptide combination studies, the blend also removes one source of potential dosing error: there is no risk of inadvertently adding more of one component than another. The trade-off versus individual vials is flexibility: if your research requires titrating each compound independently, or if a subsequent study requires a different ratio, individual vials are more appropriate. For standard multi-pathway tissue repair research where the fixed ratio reflects the most commonly cited combination in the literature, KLOW provides a streamlined and reproducible preparation.

Question 5

Where can I buy the KLOW peptide blend in Australia?

Accepted Answer

RetaLABS supplies the KLOW peptide blend as an 80mg vial (GHK-Cu 50mg, KPV 10mg, BPC-157 10mg, TB-500 10mg) to Australian research customers, dispatched via Express Post in discrete, unmarked packaging within 1–2 business days of confirmed payment, with no surcharge on cryptocurrency orders. A certificate of analysis is available on request. KLOW is supplied strictly as a research-grade compound for laboratory use only and not for human consumption. For the mechanistic background on each of the four components, see the KLOW Blend Research Guide.

KLOW 80mg

Batch & testing

Customer Reviews

Product Specifications

Frequently Asked Questions

Research Guides